,Diagnosis,Treatment code,Diagnosis code,case Specialism code,Diagnosis Treatment Combination ID,Age,Case ID,Activity,Producer code,Section,Specialism code,group,Number of executions,Complete Timestamp,duration,month,weekday,hour,remtime,elapsed,case_length
337,maligniteit cervix,TC3201,DC822,SC7,DTC395310,52.0,2_2,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-01-03 09:00:00,0.0,1.0,0.0,9.0,69811200.0,0.0,2
338,maligniteit cervix,TC3201,DC822,SC7,DTC395310,52.0,2_2,AC10113,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-01-03 09:00:00,0.0,1.0,0.0,9.0,69811200.0,0.0,2
1202,maligniteit ovarium | tuba,TC101,M16,SC7,other,71.0,9_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-08 09:00:00,0.0,1.0,5.0,9.0,8640000.0,0.0,2
1426,maligniteit cervix,TC113,M13,SC61,DTC229311,83.0,10_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-10 09:00:00,0.0,1.0,0.0,9.0,12873600.0,0.0,2
1427,maligniteit cervix,TC113,M13,SC61,DTC229311,83.0,10_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-10 09:00:00,0.0,1.0,0.0,9.0,12873600.0,0.0,2
1543,maligniteit ovarium | tuba,TC603,M16,SC7,DTC154699,72.0,11_2,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2005-01-10 09:00:00,0.0,1.0,0.0,9.0,2764800.0,0.0,2
1544,maligniteit ovarium | tuba,TC603,M16,SC7,DTC154699,72.0,11_2,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2005-01-10 09:00:00,0.0,1.0,0.0,9.0,2764800.0,0.0,2
2531,Maligne neoplasma cervix uteri,TC32,DC106,SC13,DTC165717,41.0,12_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2005-01-11 09:00:00,0.0,1.0,1.0,9.0,98668800.0,0.0,2
2532,Maligne neoplasma cervix uteri,TC32,DC106,SC13,DTC165717,41.0,12_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-11 09:00:00,0.0,1.0,1.0,9.0,98668800.0,0.0,2
2976,maligniteit vulva,TC813,M11,SC7,DTC156193,84.0,14_2,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,90115200.0,0.0,2
2977,maligniteit vulva,TC813,M11,SC7,DTC156193,84.0,14_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,90115200.0,0.0,2
3017,maligniteit vulva,TC101,M11,SC7,DTC55501,55.0,15_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,97977600.0,0.0,2
3021,Gynaecologische tumoren,TC61,DC106,SC7,other,79.0,16_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,52099200.0,0.0,2
3022,Gynaecologische tumoren,TC61,DC106,SC7,other,79.0,16_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,52099200.0,0.0,2
3139,maligniteit ovarium | tuba,TC803,M16,SC7,DTC156083,53.0,17_2,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,1987200.0,0.0,2
3140,maligniteit ovarium | tuba,TC803,M16,SC7,DTC156083,53.0,17_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,1987200.0,0.0,2
3267,maligniteit ovarium | tuba,TC803,M16,SC7,DTC156150,73.0,18_2,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,2073600.0,0.0,2
3268,maligniteit ovarium | tuba,TC803,M16,SC7,DTC156150,73.0,18_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-12 09:00:00,0.0,1.0,2.0,9.0,2073600.0,0.0,2
1200,maligniteit ovarium | tuba,TC101,M16,SC7,other,71.0,9_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-13 09:00:00,0.0,1.0,3.0,9.0,8208000.0,432000.0,2
3410,maligniteit cervix,TC113,DC822,SC61,DTC177135,86.0,20_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-13 09:00:00,0.0,1.0,3.0,9.0,39052800.0,0.0,2
3411,maligniteit cervix,TC113,DC822,SC61,DTC177135,86.0,20_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-13 09:00:00,0.0,1.0,3.0,9.0,39052800.0,0.0,2
4788,maligniteit cervix,TC101,M13,SC7,DTC161617,51.0,25_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-01-19 09:00:00,0.0,1.0,2.0,9.0,37324800.0,0.0,2
4789,maligniteit cervix,TC101,M13,SC7,DTC161617,51.0,25_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-19 09:00:00,0.0,1.0,2.0,9.0,37324800.0,0.0,2
4907,maligniteit ovarium | tuba,TC101,M16,SC7,other,63.0,28_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-19 09:00:00,0.0,1.0,2.0,9.0,39398400.0,0.0,2
4908,maligniteit ovarium | tuba,TC101,M16,SC7,other,63.0,28_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-19 09:00:00,0.0,1.0,2.0,9.0,39398400.0,0.0,2
5045,maligniteit ovarium | tuba,TC101,M16,SC7,DTC238155,71.0,29_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-21 09:00:00,0.0,1.0,4.0,9.0,93571200.0,0.0,2
5811,maligniteit myometrium,TC101,M15,SC7,DTC270518,36.0,34_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-29 09:00:00,0.0,1.0,5.0,9.0,98841600.0,0.0,2
6346,maligniteit ovarium | tuba,TC101,M16,SC7,DTC169839,59.0,38_2,AC372417,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-02 09:00:00,0.0,2.0,2.0,9.0,97286400.0,0.0,2
6347,maligniteit ovarium | tuba,TC101,M16,SC7,DTC169839,59.0,38_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-02 09:00:00,0.0,2.0,2.0,9.0,97286400.0,0.0,2
6652,maligniteit vulva,TC101,M11,SC7,DTC179034,77.0,41_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-03 09:00:00,0.0,2.0,3.0,9.0,93139200.0,0.0,2
6653,maligniteit vulva,TC101,M11,SC7,DTC179034,77.0,41_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-03 09:00:00,0.0,2.0,3.0,9.0,93139200.0,0.0,2
6664,maligniteit cervix,TC101,M13,SC7,other,32.0,42_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-03 09:00:00,0.0,2.0,3.0,9.0,25315200.0,0.0,2
6852,maligniteit endometrium,TC101,M14,SC7,DTC247860,65.0,44_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-04 09:00:00,0.0,2.0,4.0,9.0,68169600.0,0.0,2
7483,maligniteit ovarium | tuba,TC803,M16,SC7,DTC172686,65.0,48_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-07 09:00:00,0.0,2.0,0.0,9.0,10454400.0,0.0,2
7484,maligniteit ovarium | tuba,TC803,M16,SC7,DTC172686,65.0,48_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-07 09:00:00,0.0,2.0,0.0,9.0,10454400.0,0.0,2
8134,maligniteit cervix,TC803,M13,SC7,DTC175314,41.0,58_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-10 09:00:00,0.0,2.0,3.0,9.0,6566400.0,0.0,2
8135,maligniteit cervix,TC803,M13,SC7,DTC175314,41.0,58_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-10 09:00:00,0.0,2.0,3.0,9.0,6566400.0,0.0,2
8172,maligniteit ovarium | tuba,TC603,M16,SC7,DTC140498,48.0,59_2,AC40014,H5ZU,Section 2,SC7,Nursing ward,1.0,2005-02-10 09:00:00,0.0,2.0,3.0,9.0,4233600.0,0.0,2
8173,maligniteit ovarium | tuba,TC603,M16,SC7,DTC140498,48.0,59_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-10 09:00:00,0.0,2.0,3.0,9.0,4233600.0,0.0,2
8200,maligniteit vulva,TC101,M11,SC7,other,84.0,61_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-12 09:00:00,0.0,2.0,5.0,9.0,26956800.0,0.0,2
8367,maligniteit cervix,TC9101,DC822,SC13,DTC177222,39.0,62_2,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-02-14 09:00:00,0.0,2.0,0.0,9.0,31017600.0,0.0,2
8368,maligniteit cervix,TC9101,DC822,SC13,DTC177222,39.0,62_2,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-02-14 09:00:00,0.0,2.0,0.0,9.0,31017600.0,0.0,2
9148,maligniteit myometrium,TC103,M15,SC7,DTC177951,56.0,64_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-15 09:00:00,0.0,2.0,1.0,9.0,1296000.0,0.0,2
9149,maligniteit myometrium,TC103,M15,SC7,DTC177951,56.0,64_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-15 09:00:00,0.0,2.0,1.0,9.0,1296000.0,0.0,2
11123,maligniteit vulva,TC101,M11,SC7,DTC217629,73.0,73_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-18 09:00:00,0.0,2.0,4.0,9.0,94176000.0,0.0,2
11131,Gynaecologische tumoren,TC61,DC106,SC7,other,43.0,74_2,AC10307,SGEH,Section 2,SC7,Nursing ward,1.0,2005-02-18 09:00:00,0.0,2.0,4.0,9.0,51321600.0,0.0,2
3016,maligniteit vulva,TC101,M11,SC7,DTC55501,55.0,15_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-21 09:00:00,57600.0,2.0,0.0,9.0,94521600.0,3456000.0,2
11996,Recidieven (pre)maligniteit cervix uteri (ov),TC103,M13,SC13,DTC392290,45.0,76_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-02-21 09:00:00,0.0,2.0,0.0,9.0,92966400.0,0.0,2
13157,maligniteit ovarium,TC803,DC821,SC13,DTC215099,71.0,77_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-21 09:00:00,0.0,2.0,0.0,9.0,96163200.0,0.0,2
13158,maligniteit ovarium,TC803,DC821,SC13,DTC215099,71.0,77_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-21 09:00:00,0.0,2.0,0.0,9.0,96163200.0,0.0,2
13580,maligniteit cervix,TC101,M13,SC7,other,48.0,82_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-02-24 09:00:00,0.0,2.0,3.0,9.0,41731200.0,0.0,2
13581,maligniteit cervix,TC101,M13,SC7,other,48.0,82_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-24 09:00:00,0.0,2.0,3.0,9.0,41731200.0,0.0,2
13597,maligniteit ovarium | tuba,TC101,M16,SC7,other,57.0,84_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-02-24 09:00:00,0.0,2.0,3.0,9.0,64713600.0,0.0,2
13598,maligniteit ovarium | tuba,TC101,M16,SC7,other,57.0,84_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-24 09:00:00,0.0,2.0,3.0,9.0,64713600.0,0.0,2
13610,maligniteit cervix,TC101,M13,SC7,other,44.0,86_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-28 09:00:00,0.0,2.0,0.0,9.0,0.0,0.0,2
13611,maligniteit cervix,TC101,M13,SC7,other,44.0,86_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-28 09:00:00,0.0,2.0,0.0,9.0,0.0,0.0,2
14657,maligniteit cervix,TC103,M13,SC61,DTC201794,43.0,88_2,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-02-28 09:00:00,0.0,2.0,0.0,9.0,15379200.0,0.0,2
14658,maligniteit cervix,TC103,M13,SC61,DTC201794,43.0,88_2,AC10113,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-02-28 09:00:00,0.0,2.0,0.0,9.0,15379200.0,0.0,2
14748,maligniteit ovarium | tuba,TC803,M16,SC7,DTC187204,58.0,89_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-02 09:00:00,0.0,3.0,2.0,9.0,29030400.0,0.0,2
14749,maligniteit ovarium | tuba,TC803,M16,SC7,DTC187204,58.0,89_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-02 09:00:00,0.0,3.0,2.0,9.0,29030400.0,0.0,2
15201,maligniteit ovarium | tuba,TC803,DC821,SC7,DTC187241,63.0,90_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-02 09:00:00,0.0,3.0,2.0,9.0,95472000.0,0.0,2
15202,maligniteit ovarium | tuba,TC803,DC821,SC7,DTC187241,63.0,90_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-02 09:00:00,0.0,3.0,2.0,9.0,95472000.0,0.0,2
16195,maligniteit cervix,TC61,DC822,SC61,DTC232764,71.0,97_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,94435200.0,0.0,2
16196,maligniteit cervix,TC61,DC822,SC61,DTC232764,71.0,97_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,94435200.0,0.0,2
17067,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC207533,69.0,100_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,95126400.0,0.0,2
17086,maligniteit cervix,TC101,M13,SC7,DTC222842,52.0,101_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-08 09:00:00,0.0,3.0,1.0,9.0,92707200.0,0.0,2
17593,maligniteit cervix,TC101,M13,SC7,other,51.0,108_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-10 09:00:00,0.0,3.0,3.0,9.0,63504000.0,0.0,2
17613,maligniteit ovarium | tuba,TC101,M16,SC7,DTC203747,47.0,109_2,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-11 09:00:00,0.0,3.0,4.0,9.0,65232000.0,0.0,2
17614,maligniteit ovarium | tuba,TC101,M16,SC7,DTC203747,47.0,109_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-11 09:00:00,0.0,3.0,4.0,9.0,65232000.0,0.0,2
17736,maligniteit vulva,TC101,M11,SC7,other,77.0,111_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-14 09:00:00,0.0,3.0,0.0,9.0,49593600.0,0.0,2
17737,maligniteit vulva,TC101,M11,SC7,other,77.0,111_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-14 09:00:00,0.0,3.0,0.0,9.0,49593600.0,0.0,2
17886,Gynaecologische tumoren,TC61,DC106,SC7,DTC309350,45.0,113_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-15 09:00:00,0.0,3.0,1.0,9.0,59529600.0,0.0,2
19593,Maligne neoplasma adnexa uteri,TC101,DC839,SC13,DTC464231,57.0,119_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-16 09:00:00,0.0,3.0,2.0,9.0,94176000.0,0.0,2
19686,maligniteit vulva,TC101,M11,SC7,other,91.0,121_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,23500800.0,0.0,2
19960,Gynaecologische tumoren,TC12,DC106,SC61,DTC390635,62.0,124_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,57456000.0,0.0,2
19961,Gynaecologische tumoren,TC12,DC106,SC61,DTC390635,62.0,124_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,57456000.0,0.0,2
20283,maligniteit cervix,TC103,DC822,SC61,DTC224693,58.0,127_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,55036800.0,0.0,2
20284,maligniteit cervix,TC103,DC822,SC61,DTC224693,58.0,127_2,370711S,CITH,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,55036800.0,0.0,2
20371,Gynaecologische tumoren,TC61,DC106,SC7,DTC310159,47.0,129_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,93571200.0,0.0,2
21802,maligniteit vulva,TC101,M11,SC7,DTC200214,70.0,133_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,84067200.0,0.0,2
21803,maligniteit vulva,TC101,M11,SC7,DTC200214,70.0,133_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,84067200.0,0.0,2
17592,maligniteit cervix,TC101,M13,SC7,other,51.0,108_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-27 09:00:00,24480.0,3.0,6.0,9.0,62035200.0,1468800.0,2
22746,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC402035,39.0,139_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-27 09:00:00,0.0,3.0,6.0,9.0,70416000.0,0.0,2
22825,maligniteit endometrium,TC613,M14,SC7,DTC246929,51.0,140_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-03-29 09:00:00,0.0,3.0,1.0,9.0,6480000.0,0.0,2
22826,maligniteit endometrium,TC613,M14,SC7,DTC246929,51.0,140_2,other,SLVE,Section 4,SC86,Special lab radiology,1.0,2005-03-29 09:00:00,0.0,3.0,1.0,9.0,6480000.0,0.0,2
22841,maligniteit vulva,TC101,M11,SC7,other,73.0,141_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,32054400.0,0.0,2
22842,maligniteit vulva,TC101,M11,SC7,other,73.0,141_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,32054400.0,0.0,2
23115,maligniteit cervix,TC101,M13,SC7,other,38.0,147_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,2
23116,maligniteit cervix,TC101,M13,SC7,other,38.0,147_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,2
23251,maligniteit ovarium | tuba,TC101,M16,SC7,DTC203111,63.0,150_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,89424000.0,0.0,2
23252,maligniteit ovarium | tuba,TC101,M16,SC7,DTC203111,63.0,150_2,370828A,SLVE,Section 4,SC86,Special lab radiology,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,89424000.0,0.0,2
23471,Gynaecologische tumoren,TC61,DC106,SC7,DTC205671,46.0,158_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-04 09:00:00,0.0,4.0,0.0,9.0,50803200.0,0.0,2
23472,Gynaecologische tumoren,TC61,DC106,SC7,DTC205671,46.0,158_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-04 09:00:00,0.0,4.0,0.0,9.0,50803200.0,0.0,2
17066,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC207533,69.0,100_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-06 09:00:00,43200.0,4.0,2.0,9.0,92534400.0,2592000.0,2
23555,maligniteit cervix,TC101,M13,SC7,other,39.0,162_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-06 09:00:00,0.0,4.0,2.0,9.0,64108800.0,0.0,2
23556,maligniteit cervix,TC101,M13,SC7,other,39.0,162_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-06 09:00:00,0.0,4.0,2.0,9.0,64108800.0,0.0,2
23692,maligniteit vulva,TC101,M11,SC7,other,67.0,164_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,89424000.0,0.0,2
23838,Gynaecologische tumoren,TC61,DC106,SC7,DTC208337,46.0,167_2,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,79574400.0,0.0,2
23839,Gynaecologische tumoren,TC61,DC106,SC7,DTC208337,46.0,167_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,79574400.0,0.0,2
24238,Gynaecologische tumoren,TC61,DC106,SC7,other,71.0,174_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-13 09:00:00,0.0,4.0,2.0,9.0,48470400.0,0.0,2
24239,Gynaecologische tumoren,TC61,DC106,SC7,other,71.0,174_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-13 09:00:00,0.0,4.0,2.0,9.0,48470400.0,0.0,2
24332,maligniteit cervix,TC813,M13,SC7,DTC212333,45.0,175_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-13 09:00:00,0.0,4.0,2.0,9.0,8467200.0,0.0,2
24333,maligniteit cervix,TC813,M13,SC7,DTC212333,45.0,175_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-13 09:00:00,0.0,4.0,2.0,9.0,8467200.0,0.0,2
24362,maligniteit cervix,TC101,M13,SC7,other,49.0,176_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-13 09:00:00,0.0,4.0,2.0,9.0,0.0,0.0,2
24363,maligniteit cervix,TC101,M13,SC7,other,49.0,176_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-13 09:00:00,0.0,4.0,2.0,9.0,0.0,0.0,2
24521,maligniteit ovarium | tuba,TC101,M16,SC7,DTC229523,60.0,181_2,AC10307,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-17 09:00:00,0.0,4.0,6.0,9.0,91065600.0,0.0,2
24556,maligniteit cervix,TC101,M13,SC7,other,54.0,184_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-19 09:00:00,0.0,4.0,1.0,9.0,11577600.0,0.0,2
24606,maligniteit cervix,TC61,DC106,SC61,other,85.0,187_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-20 09:00:00,0.0,4.0,2.0,9.0,79315200.0,0.0,2
24607,maligniteit cervix,TC61,DC106,SC61,other,85.0,187_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-20 09:00:00,0.0,4.0,2.0,9.0,79315200.0,0.0,2
11121,maligniteit vulva,TC101,M11,SC7,DTC217629,73.0,73_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-21 09:00:00,0.0,4.0,3.0,9.0,88819200.0,5356800.0,2
24630,maligniteit ovarium | tuba,TC101,M16,SC7,DTC217675,69.0,189_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-21 09:00:00,0.0,4.0,3.0,9.0,85881600.0,0.0,2
24631,maligniteit ovarium | tuba,TC101,M16,SC7,DTC217675,69.0,189_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-21 09:00:00,0.0,4.0,3.0,9.0,85881600.0,0.0,2
22743,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC402035,39.0,139_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,67910400.0,2505600.0,2
25304,Plav.celcarc. vulva: st I,TC101,M11,SC7,DTC220052,79.0,192_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,83462400.0,0.0,2
26045,maligniteit cervix,TC813,DC822,SC61,DTC264024,43.0,194_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,38275200.0,0.0,2
26046,maligniteit cervix,TC813,DC822,SC61,DTC264024,43.0,194_2,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,38275200.0,0.0,2
26363,maligniteit ovarium | tuba,TC3101,DC822,SC13,DTC293450,59.0,195_2,370701S,CRPO,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,30326400.0,0.0,2
26364,maligniteit ovarium | tuba,TC3101,DC822,SC13,DTC293450,59.0,195_2,370419S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,30326400.0,0.0,2
6851,maligniteit endometrium,TC101,M14,SC7,DTC247860,65.0,44_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,118080.0,4.0,2.0,9.0,61084800.0,7084800.0,2
19592,Maligne neoplasma adnexa uteri,TC101,DC839,SC13,DTC464231,57.0,119_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,60480.0,4.0,2.0,9.0,90547200.0,3628800.0,2
26554,maligniteit cervix,TC103,M13,SC7,DTC222012,58.0,198_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,7862400.0,0.0,2
26555,maligniteit cervix,TC103,M13,SC7,DTC222012,58.0,198_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,7862400.0,0.0,2
26990,maligniteit cervix,TC61,DC106,SC61,DTC392371,26.0,199_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,17625600.0,0.0,2
27050,maligniteit cervix,TC510,M13,SC7,DTC221936,43.0,200_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,12096000.0,0.0,2
27051,maligniteit cervix,TC510,M13,SC7,DTC221936,43.0,200_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,12096000.0,0.0,2
27099,maligniteit cervix,TC101,M13,SC7,DTC221377,42.0,202_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,50976000.0,0.0,2
17081,maligniteit cervix,TC101,M13,SC7,DTC222842,52.0,101_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-28 09:00:00,0.0,4.0,3.0,9.0,88300800.0,4406400.0,2
6662,maligniteit cervix,TC101,M13,SC7,other,32.0,42_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-02 09:00:00,0.0,5.0,0.0,9.0,17712000.0,7603200.0,2
27199,Gynaecologische tumoren,TC61,DC106,SC7,DTC226309,50.0,207_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-04 09:00:00,0.0,5.0,2.0,9.0,48816000.0,0.0,2
27200,Gynaecologische tumoren,TC61,DC106,SC7,DTC226309,50.0,207_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-04 09:00:00,0.0,5.0,2.0,9.0,48816000.0,0.0,2
27207,Gynaecologische tumoren,TC61,DC106,SC7,other,42.0,208_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-04 09:00:00,0.0,5.0,2.0,9.0,78105600.0,0.0,2
27208,Gynaecologische tumoren,TC61,DC106,SC7,other,42.0,208_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-04 09:00:00,0.0,5.0,2.0,9.0,78105600.0,0.0,2
28268,maligniteit endometrium,TC3101,DC823,SC7,DTC227929,64.0,210_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-09 09:00:00,0.0,5.0,0.0,9.0,39484800.0,0.0,2
28269,maligniteit endometrium,TC3101,DC823,SC7,DTC227929,64.0,210_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-09 09:00:00,0.0,5.0,0.0,9.0,39484800.0,0.0,2
28345,maligniteit vulva,TC101,M11,SC7,DTC273249,57.0,211_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-10 09:00:00,0.0,5.0,1.0,9.0,87868800.0,0.0,2
24520,maligniteit ovarium | tuba,TC101,M16,SC7,DTC229523,60.0,181_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-11 09:00:00,34560.0,5.0,2.0,9.0,88992000.0,2073600.0,2
28458,maligniteit cervix,TC101,M13,SC7,DTC229555,33.0,216_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,82252800.0,0.0,2
29066,maligniteit cervix,TC61,DC106,SC61,other,53.0,221_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-14 09:00:00,0.0,5.0,5.0,9.0,58492800.0,0.0,2
29078,maligniteit cervix,TC61,DC106,SC61,DTC803549,61.0,222_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-16 09:00:00,0.0,5.0,0.0,9.0,49248000.0,0.0,2
29156,Gynaecologische tumoren,TC13,DC106,SC61,DTC787870,70.0,223_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-16 09:00:00,0.0,5.0,0.0,9.0,61344000.0,0.0,2
26986,maligniteit cervix,TC61,DC106,SC61,DTC392371,26.0,199_2,AC613000,H5ZU,Section 2,SC7,Nursing ward,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,15811200.0,1814400.0,2
29165,maligniteit vulva,TC101,M11,SC7,DTC233586,73.0,224_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,79833600.0,0.0,2
29166,maligniteit vulva,TC101,M11,SC7,DTC233586,73.0,224_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,79833600.0,0.0,2
29180,Gynaecologische tumoren,TC61,DC106,SC7,other,72.0,226_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,62899200.0,0.0,2
29183,maligniteit cervix,TC101,M13,SC7,other,40.0,227_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,34473600.0,0.0,2
29184,maligniteit cervix,TC101,M13,SC7,other,40.0,227_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,34473600.0,0.0,2
29949,maligniteit vulva,TC101,M11,SC7,other,73.0,230_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-21 09:00:00,0.0,5.0,5.0,9.0,60220800.0,0.0,2
29155,Gynaecologische tumoren,TC13,DC106,SC61,DTC787870,70.0,223_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-23 09:00:00,10080.0,5.0,0.0,9.0,60739200.0,604800.0,2
30049,maligniteit endometrium,TC101,M14,SC7,DTC246740,55.0,232_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-23 09:00:00,0.0,5.0,0.0,9.0,81129600.0,0.0,2
5042,maligniteit ovarium | tuba,TC101,M16,SC7,DTC238155,71.0,29_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,82857600.0,10713600.0,2
30894,maligniteit vulva,TC101,M11,SC7,other,58.0,235_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,2
30895,maligniteit vulva,TC101,M11,SC7,other,58.0,235_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,2
32021,maligniteit endometrium,TC101,M14,SC7,other,73.0,242_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,75600000.0,0.0,2
32022,maligniteit endometrium,TC101,M14,SC7,other,73.0,242_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,75600000.0,0.0,2
32205,maligniteit cervix,TC101,M13,SC7,DTC241211,56.0,245_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-30 09:00:00,0.0,5.0,0.0,9.0,87436800.0,0.0,2
32206,maligniteit cervix,TC101,M13,SC7,DTC241211,56.0,245_2,AC372439,SLVE,Section 4,SC86,Special lab radiology,1.0,2005-05-30 09:00:00,0.0,5.0,0.0,9.0,87436800.0,0.0,2
32532,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC268936,36.0,246_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-30 09:00:00,0.0,5.0,0.0,9.0,87868800.0,0.0,2
32533,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC268936,36.0,246_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-30 09:00:00,0.0,5.0,0.0,9.0,87868800.0,0.0,2
33349,maligniteit ovarium | tuba,TC803,M16,SC7,DTC243184,68.0,250_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-01 09:00:00,0.0,6.0,2.0,9.0,8899200.0,0.0,2
33350,maligniteit ovarium | tuba,TC803,M16,SC7,DTC243184,68.0,250_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-01 09:00:00,0.0,6.0,2.0,9.0,8899200.0,0.0,2
23690,maligniteit vulva,TC101,M11,SC7,other,67.0,164_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-02 09:00:00,0.0,6.0,3.0,9.0,84585600.0,4838400.0,2
33513,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC250610,51.0,253_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-02 09:00:00,0.0,6.0,3.0,9.0,41126400.0,0.0,2
33514,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC250610,51.0,253_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-02 09:00:00,0.0,6.0,3.0,9.0,41126400.0,0.0,2
34293,maligniteit ovarium | tuba,TC103,M16,SC61,DTC301600,82.0,260_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,8640000.0,0.0,2
34294,maligniteit ovarium | tuba,TC103,M16,SC61,DTC301600,82.0,260_2,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,8640000.0,0.0,2
34353,maligniteit endometrium,TC101,M14,SC7,DTC290856,55.0,263_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-09 09:00:00,0.0,6.0,3.0,9.0,55036800.0,0.0,2
29076,maligniteit cervix,TC61,DC106,SC61,DTC803549,61.0,222_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-13 09:00:00,0.0,6.0,0.0,9.0,46828800.0,2419200.0,2
34542,maligniteit ovarium | tuba,TC603,M16,SC7,DTC254438,70.0,266_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-13 09:00:00,0.0,6.0,0.0,9.0,1468800.0,0.0,2
34543,maligniteit ovarium | tuba,TC603,M16,SC7,DTC254438,70.0,266_2,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-13 09:00:00,0.0,6.0,0.0,9.0,1468800.0,0.0,2
34607,Gynaecologische tumoren,TC62,DC106,SC7,DTC315045,42.0,268_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-14 09:00:00,0.0,6.0,1.0,9.0,60393600.0,0.0,2
34625,maligniteit ovarium | tuba,TC101,M16,SC7,DTC251292,41.0,269_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-14 09:00:00,0.0,6.0,1.0,9.0,73180800.0,0.0,2
34626,maligniteit ovarium | tuba,TC101,M16,SC7,DTC251292,41.0,269_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-14 09:00:00,0.0,6.0,1.0,9.0,73180800.0,0.0,2
19684,maligniteit vulva,TC101,M11,SC7,other,91.0,121_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-15 09:00:00,0.0,6.0,2.0,9.0,15724800.0,7776000.0,2
34913,maligniteit endometrium,TC101,M14,SC7,other,68.0,271_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-15 09:00:00,0.0,6.0,2.0,9.0,67737600.0,0.0,2
34914,maligniteit endometrium,TC101,M14,SC7,other,68.0,271_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-15 09:00:00,0.0,6.0,2.0,9.0,67737600.0,0.0,2
34960,maligniteit cervix,TC101,M13,SC7,other,45.0,274_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-16 09:00:00,0.0,6.0,3.0,9.0,0.0,0.0,2
34961,maligniteit cervix,TC101,M13,SC7,other,45.0,274_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-16 09:00:00,0.0,6.0,3.0,9.0,0.0,0.0,2
34973,Gynaecologische tumoren,TC13,DC106,SC7,DTC253037,77.0,275_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-16 09:00:00,0.0,6.0,3.0,9.0,82252800.0,0.0,2
34974,Gynaecologische tumoren,TC13,DC106,SC7,DTC253037,77.0,275_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-16 09:00:00,0.0,6.0,3.0,9.0,82252800.0,0.0,2
11129,Gynaecologische tumoren,TC61,DC106,SC7,other,43.0,74_2,AC411100,SGEH,Section 2,SC7,Nursing ward,1.0,2005-06-19 09:00:00,0.0,6.0,6.0,9.0,40867200.0,10454400.0,2
35075,Gynaecologische tumoren,TC61,DC106,SC7,DTC449929,50.0,278_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-20 09:00:00,0.0,6.0,0.0,9.0,68947200.0,0.0,2
35076,Gynaecologische tumoren,TC61,DC106,SC7,DTC449929,50.0,278_2,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2005-06-20 09:00:00,0.0,6.0,0.0,9.0,68947200.0,0.0,2
8199,maligniteit vulva,TC101,M11,SC7,other,84.0,61_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,187200.0,6.0,2.0,9.0,15724800.0,11232000.0,2
35172,maligniteit vulva,TC101,M11,SC7,DTC256757,80.0,280_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,84758400.0,0.0,2
35173,maligniteit vulva,TC101,M11,SC7,DTC256757,80.0,280_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,84758400.0,0.0,2
35676,maligniteit cervix,TC101,M13,SC7,other,69.0,289_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,0.0,0.0,2
35677,maligniteit cervix,TC101,M13,SC7,other,69.0,289_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,0.0,0.0,2
35942,maligniteit endometrium,TC101,M14,SC61,DTC390356,59.0,293_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,81734400.0,0.0,2
35943,maligniteit endometrium,TC101,M14,SC61,DTC390356,59.0,293_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,81734400.0,0.0,2
36565,Maligne neoplasma cervix uteri,TC61,DC822,SC61,DTC297647,50.0,296_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-30 09:00:00,0.0,6.0,3.0,9.0,84067200.0,0.0,2
36566,Maligne neoplasma cervix uteri,TC61,DC822,SC61,DTC297647,50.0,296_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-30 09:00:00,0.0,6.0,3.0,9.0,84067200.0,0.0,2
36614,maligniteit ovarium | tuba,TC101,M16,SC7,DTC270582,59.0,298_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-02 09:00:00,0.0,7.0,5.0,9.0,1555200.0,0.0,2
36705,maligniteit vulva,TC603,M11,SC7,DTC263801,80.0,299_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-03 09:00:00,0.0,7.0,6.0,9.0,70502400.0,0.0,2
36703,maligniteit vulva,TC603,M11,SC7,DTC263801,80.0,299_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-04 09:00:00,0.0,7.0,0.0,9.0,70416000.0,86400.0,2
37170,maligniteit endometrium,TC103,M14,SC7,DTC549031,54.0,303_2,370488T,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-04 09:00:00,0.0,7.0,0.0,9.0,691200.0,0.0,2
37171,maligniteit endometrium,TC103,M14,SC7,DTC549031,54.0,303_2,370403S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-04 09:00:00,0.0,7.0,0.0,9.0,691200.0,0.0,2
25303,Plav.celcarc. vulva: st I,TC101,M11,SC7,DTC220052,79.0,192_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-05 09:00:00,102240.0,7.0,1.0,9.0,77328000.0,6134400.0,2
37223,maligniteit vulva,TC101,M11,SC7,other,84.0,305_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-06 09:00:00,0.0,7.0,2.0,9.0,24192000.0,0.0,2
37265,maligniteit cervix,TC603,M13,SC7,DTC266024,52.0,306_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-06 09:00:00,0.0,7.0,2.0,9.0,76723200.0,0.0,2
37266,maligniteit cervix,TC603,M13,SC7,DTC266024,52.0,306_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-06 09:00:00,0.0,7.0,2.0,9.0,76723200.0,0.0,2
37307,maligniteit ovarium | tuba,TC101,M16,SC7,other,59.0,308_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-06 09:00:00,0.0,7.0,2.0,9.0,72576000.0,0.0,2
37308,maligniteit ovarium | tuba,TC101,M16,SC7,other,59.0,308_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-06 09:00:00,0.0,7.0,2.0,9.0,72576000.0,0.0,2
37604,maligniteit vulva,TC503,M11,SC7,DTC266947,74.0,311_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-07 09:00:00,0.0,7.0,3.0,9.0,5356800.0,0.0,2
37605,maligniteit vulva,TC503,M11,SC7,DTC266947,74.0,311_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-07 09:00:00,0.0,7.0,3.0,9.0,5356800.0,0.0,2
37646,maligniteit endometrium,TC101,M14,SC7,DTC322180,69.0,314_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-08 09:00:00,0.0,7.0,4.0,9.0,80784000.0,0.0,2
37645,maligniteit endometrium,TC101,M14,SC7,DTC322180,69.0,314_2,387042A,SRA6,Section 5,SC62,Radiology,1.0,2005-07-12 09:00:00,5760.0,7.0,1.0,9.0,80438400.0,345600.0,2
37974,maligniteit cervix,TC103,M13,SC7,DTC274807,41.0,317_2,370402S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-12 09:00:00,0.0,7.0,1.0,9.0,1987200.0,0.0,2
37975,maligniteit cervix,TC103,M13,SC7,DTC274807,41.0,317_2,370421S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-12 09:00:00,0.0,7.0,1.0,9.0,1987200.0,0.0,2
38016,Gynaecologische tumoren,TC61,DC106,SC7,other,63.0,318_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-12 09:00:00,0.0,7.0,1.0,9.0,58838400.0,0.0,2
38023,Gynaecologische tumoren,TC61,DC106,SC7,other,80.0,319_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-12 09:00:00,0.0,7.0,1.0,9.0,62208000.0,0.0,2
5809,maligniteit myometrium,TC101,M15,SC7,DTC270518,36.0,34_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-13 09:00:00,0.0,7.0,2.0,9.0,84585600.0,14256000.0,2
36603,maligniteit ovarium | tuba,TC101,M16,SC7,DTC270582,59.0,298_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-13 09:00:00,0.0,7.0,2.0,9.0,604800.0,950400.0,2
38262,maligniteit cervix,TC101,M13,SC7,other,52.0,324_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-14 09:00:00,0.0,7.0,3.0,9.0,68256000.0,0.0,2
28343,maligniteit vulva,TC101,M11,SC7,DTC273249,57.0,211_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-18 09:00:00,0.0,7.0,0.0,9.0,81907200.0,5961600.0,2
29947,maligniteit vulva,TC101,M11,SC7,other,73.0,230_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,55036800.0,5184000.0,2
38260,maligniteit cervix,TC101,M13,SC7,other,52.0,324_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,67737600.0,518400.0,2
39109,maligniteit vulva,TC101,M11,SC7,other,73.0,331_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,71366400.0,0.0,2
39868,Gynaecologische tumoren,TC101,DC106,SC61,DTC785776,85.0,332_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,82857600.0,0.0,2
39869,Gynaecologische tumoren,TC101,DC106,SC61,DTC785776,85.0,332_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,82857600.0,0.0,2
39963,Maligne neoplasma vulva,TC3104,DC839,SC7,DTC275114,85.0,333_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,35683200.0,0.0,2
39964,Maligne neoplasma vulva,TC3104,DC839,SC7,DTC275114,85.0,333_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,35683200.0,0.0,2
40011,maligniteit vagina,TC101,M12,SC7,DTC274946,42.0,334_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,49593600.0,0.0,2
40012,maligniteit vagina,TC101,M12,SC7,DTC274946,42.0,334_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,49593600.0,0.0,2
40297,maligniteit ovarium | tuba,TC101,M16,SC7,DTC274937,64.0,335_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,81043200.0,0.0,2
38014,Gynaecologische tumoren,TC61,DC106,SC7,other,63.0,318_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-21 09:00:00,0.0,7.0,3.0,9.0,58060800.0,777600.0,2
40336,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC281540,51.0,336_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-07-21 09:00:00,0.0,7.0,3.0,9.0,57196800.0,0.0,2
40337,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC281540,51.0,336_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-07-21 09:00:00,0.0,7.0,3.0,9.0,57196800.0,0.0,2
40380,maligniteit ovarium | tuba,TC101,M16,SC7,DTC322089,37.0,338_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-22 09:00:00,0.0,7.0,4.0,9.0,7776000.0,0.0,2
42551,Maligne neoplasma cervix uteri,TC101,DC822,SC61,DTC560924,32.0,345_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,58579200.0,0.0,2
42552,Maligne neoplasma cervix uteri,TC101,DC822,SC61,DTC560924,32.0,345_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,58579200.0,0.0,2
42615,maligniteit cervix,TC101,DC106,SC7,DTC281429,73.0,346_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,72576000.0,0.0,2
42613,maligniteit cervix,TC101,DC106,SC7,DTC281429,73.0,346_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-01 09:00:00,0.0,8.0,0.0,9.0,72230400.0,345600.0,2
42859,maligniteit cervix,TC101,M13,SC7,other,65.0,352_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-02 09:00:00,0.0,8.0,1.0,9.0,33955200.0,0.0,2
42879,maligniteit endometrium,TC101,M14,SC7,DTC333715,43.0,353_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-02 09:00:00,0.0,8.0,1.0,9.0,66096000.0,0.0,2
43591,maligniteit vulva,TC813,M11,SC7,DTC285249,84.0,358_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-08 09:00:00,0.0,8.0,0.0,9.0,73353600.0,0.0,2
43592,maligniteit vulva,TC813,M11,SC7,DTC285249,84.0,358_2,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2005-08-08 09:00:00,0.0,8.0,0.0,9.0,73353600.0,0.0,2
43749,maligniteit cervix,TC101,M13,SC7,other,67.0,361_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-11 09:00:00,0.0,8.0,3.0,9.0,10800000.0,0.0,2
43756,maligniteit cervix,TC101,M13,SC7,other,48.0,362_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-13 09:00:00,0.0,8.0,5.0,9.0,74044800.0,0.0,2
34351,maligniteit endometrium,TC101,M14,SC7,DTC290856,55.0,263_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-17 09:00:00,0.0,8.0,2.0,9.0,49075200.0,5961600.0,2
42857,maligniteit cervix,TC101,M13,SC7,other,65.0,352_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-17 09:00:00,0.0,8.0,2.0,9.0,32659200.0,1296000.0,2
44209,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC390872,79.0,365_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-08-17 09:00:00,0.0,8.0,2.0,9.0,62726400.0,0.0,2
44210,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC390872,79.0,365_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-08-17 09:00:00,0.0,8.0,2.0,9.0,62726400.0,0.0,2
44239,Maligne nieuwvormingen ovarium (ov),TC101,M16,SC7,DTC291148,27.0,366_2,other,SLVE,Section 4,SC86,Special lab radiology,1.0,2005-08-17 09:00:00,0.0,8.0,2.0,9.0,73785600.0,0.0,2
44240,Maligne nieuwvormingen ovarium (ov),TC101,M16,SC7,DTC291148,27.0,366_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-17 09:00:00,0.0,8.0,2.0,9.0,73785600.0,0.0,2
44692,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC332203,39.0,371_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-23 09:00:00,0.0,8.0,1.0,9.0,63590400.0,0.0,2
44693,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC332203,39.0,371_2,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2005-08-23 09:00:00,0.0,8.0,1.0,9.0,63590400.0,0.0,2
44776,maligniteit cervix,TC101,M13,SC7,DTC319529,52.0,373_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-23 09:00:00,0.0,8.0,1.0,9.0,81043200.0,0.0,2
45101,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC317582,45.0,374_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-24 09:00:00,0.0,8.0,2.0,9.0,32400000.0,0.0,2
45102,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC317582,45.0,374_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2005-08-24 09:00:00,0.0,8.0,2.0,9.0,32400000.0,0.0,2
46804,Maligne neoplasma ovarium,TC3101,DC821,SC13,DTC297667,54.0,377_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-24 09:00:00,0.0,8.0,2.0,9.0,57024000.0,0.0,2
46805,Maligne neoplasma ovarium,TC3101,DC821,SC13,DTC297667,54.0,377_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-24 09:00:00,0.0,8.0,2.0,9.0,57024000.0,0.0,2
24554,maligniteit cervix,TC101,M13,SC7,other,54.0,184_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-31 09:00:00,0.0,8.0,2.0,9.0,0.0,11577600.0,2
38021,Gynaecologische tumoren,TC61,DC106,SC7,other,80.0,319_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-31 09:00:00,0.0,8.0,2.0,9.0,57888000.0,4320000.0,2
48013,maligniteit ovarium | tuba,TC101,M16,SC7,DTC322158,51.0,384_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-01 09:00:00,0.0,9.0,3.0,9.0,50198400.0,0.0,2
48887,maligniteit endometrium,TC3101,DC823,SC13,DTC309433,58.0,387_2,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-09-05 09:00:00,0.0,9.0,0.0,9.0,25056000.0,0.0,2
48888,maligniteit endometrium,TC3101,DC823,SC13,DTC309433,58.0,387_2,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-09-05 09:00:00,0.0,9.0,0.0,9.0,25056000.0,0.0,2
49121,maligniteit vulva,TC101,M11,SC7,other,86.0,390_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,64108800.0,0.0,2
49122,maligniteit vulva,TC101,M11,SC7,other,86.0,390_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,64108800.0,0.0,2
49153,Gynaecologische tumoren,TC61,DC106,SC7,DTC363167,89.0,391_2,AC415100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,79833600.0,0.0,2
49396,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC313464,44.0,395_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,33264000.0,0.0,2
49397,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC313464,44.0,395_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,33264000.0,0.0,2
49629,maligniteit ovarium | tuba,TC101,M16,SC7,DTC303420,51.0,397_2,AC10107,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,42336000.0,0.0,2
49630,maligniteit ovarium | tuba,TC101,M16,SC7,DTC303420,51.0,397_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,42336000.0,0.0,2
50121,Gynaecologische tumoren,TC13,DC106,SC61,DTC391454,45.0,403_2,AC378546,LBAC,Section 4,SC87,Medical Microbiology,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,57369600.0,0.0,2
50122,Gynaecologische tumoren,TC13,DC106,SC61,DTC391454,45.0,403_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,57369600.0,0.0,2
50453,maligniteit myometrium,TC101,M15,SC7,other,57.0,407_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-12 09:00:00,0.0,9.0,0.0,9.0,24364800.0,0.0,2
50454,maligniteit myometrium,TC101,M15,SC7,other,57.0,407_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-12 09:00:00,0.0,9.0,0.0,9.0,24364800.0,0.0,2
50456,maligniteit ovarium | tuba,TC101,M16,SC7,other,60.0,408_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-12 09:00:00,0.0,9.0,0.0,9.0,0.0,0.0,2
50457,maligniteit ovarium | tuba,TC101,M16,SC7,other,60.0,408_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-12 09:00:00,0.0,9.0,0.0,9.0,0.0,0.0,2
17884,Gynaecologische tumoren,TC61,DC106,SC7,DTC309350,45.0,113_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-14 09:00:00,0.0,9.0,2.0,9.0,43718400.0,15811200.0,2
50464,maligniteit cervix,TC101,M13,SC7,other,75.0,410_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-14 09:00:00,0.0,9.0,2.0,9.0,0.0,0.0,2
50465,maligniteit cervix,TC101,M13,SC7,other,75.0,410_2,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2005-09-14 09:00:00,0.0,9.0,2.0,9.0,0.0,0.0,2
20369,Gynaecologische tumoren,TC61,DC106,SC7,DTC310159,47.0,129_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-15 09:00:00,0.0,9.0,3.0,9.0,78364800.0,15206400.0,2
50942,maligniteit vulva,TC803,M11,SC7,DTC312565,74.0,417_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-19 09:00:00,0.0,9.0,0.0,9.0,29203200.0,0.0,2
50943,maligniteit vulva,TC803,M11,SC7,DTC312565,74.0,417_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-19 09:00:00,0.0,9.0,0.0,9.0,29203200.0,0.0,2
34605,Gynaecologische tumoren,TC62,DC106,SC7,DTC315045,42.0,268_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-22 09:00:00,0.0,9.0,3.0,9.0,51753600.0,8640000.0,2
51521,maligniteit cervix,TC101,M13,SC7,other,47.0,425_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-22 09:00:00,0.0,9.0,3.0,9.0,32054400.0,0.0,2
51522,maligniteit cervix,TC101,M13,SC7,other,47.0,425_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-22 09:00:00,0.0,9.0,3.0,9.0,32054400.0,0.0,2
48010,maligniteit ovarium | tuba,TC101,M16,SC7,DTC322158,51.0,384_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-26 09:00:00,0.0,9.0,0.0,9.0,48038400.0,2160000.0,2
44774,maligniteit cervix,TC101,M13,SC7,DTC319529,52.0,373_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-28 09:00:00,0.0,9.0,2.0,9.0,77932800.0,3110400.0,2
51641,maligniteit cervix,TC101,M13,SC7,other,74.0,431_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-28 09:00:00,0.0,9.0,2.0,9.0,0.0,0.0,2
51642,maligniteit cervix,TC101,M13,SC7,other,74.0,431_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-28 09:00:00,0.0,9.0,2.0,9.0,0.0,0.0,2
51879,maligniteit vulva,TC813,M11,SC7,DTC320583,82.0,432_2,AC20189,H1NO,Section 3,SC89,Recovery room / high care,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,74390400.0,0.0,2
51880,maligniteit vulva,TC813,M11,SC7,DTC320583,82.0,432_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,74390400.0,0.0,2
52025,maligniteit vulva,TC101,M11,SC7,DTC368248,52.0,434_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,75427200.0,0.0,2
52029,maligniteit cervix,TC101,M13,SC7,other,36.0,435_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,34473600.0,0.0,2
52034,maligniteit ovarium | tuba,TC101,M16,SC7,other,73.0,436_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,64713600.0,0.0,2
52035,maligniteit ovarium | tuba,TC101,M16,SC7,other,73.0,436_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,64713600.0,0.0,2
40371,maligniteit ovarium | tuba,TC101,M16,SC7,DTC322089,37.0,338_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-03 09:00:00,0.0,10.0,0.0,9.0,1468800.0,6307200.0,2
52193,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC333226,44.0,440_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-03 09:00:00,0.0,10.0,0.0,9.0,41126400.0,0.0,2
52194,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC333226,44.0,440_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-03 09:00:00,0.0,10.0,0.0,9.0,41126400.0,0.0,2
52694,maligniteit cervix,TC101,M13,SC7,other,62.0,445_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-05 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
52695,maligniteit cervix,TC101,M13,SC7,other,62.0,445_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-05 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
53163,maligniteit vulva,TC3303,DC839,SC13,DTC383910,83.0,448_2,other,other,Section 6,SC13,other,1.0,2005-10-07 09:00:00,0.0,10.0,4.0,9.0,4060800.0,0.0,2
53164,maligniteit vulva,TC3303,DC839,SC13,DTC383910,83.0,448_2,370426S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-07 09:00:00,0.0,10.0,4.0,9.0,4060800.0,0.0,2
53274,maligniteit cervix,TC101,M13,SC7,DTC334664,36.0,450_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-10 09:00:00,0.0,10.0,0.0,9.0,71107200.0,0.0,2
53718,maligniteit cervix,TC101,M13,SC7,other,73.0,455_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-17 09:00:00,0.0,10.0,0.0,9.0,0.0,0.0,2
53719,maligniteit cervix,TC101,M13,SC7,other,73.0,455_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-17 09:00:00,0.0,10.0,0.0,9.0,0.0,0.0,2
42878,maligniteit endometrium,TC101,M14,SC7,DTC333715,43.0,353_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,112320.0,10.0,2.0,9.0,59356800.0,6739200.0,2
54213,maligniteit cervix,TC101,M13,SC7,other,53.0,462_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
54214,maligniteit cervix,TC101,M13,SC7,other,53.0,462_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
53266,maligniteit cervix,TC101,M13,SC7,DTC334664,36.0,450_2,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2005-10-20 09:00:00,0.0,10.0,3.0,9.0,70243200.0,864000.0,2
54463,maligniteit cervix,TC101,M13,SC7,other,80.0,465_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-24 09:00:00,0.0,10.0,0.0,9.0,35251200.0,0.0,2
55429,maligniteit cervix,TC101,M13,SC7,other,40.0,469_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-26 09:00:00,0.0,10.0,2.0,9.0,15724800.0,0.0,2
55430,maligniteit cervix,TC101,M13,SC7,other,40.0,469_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-26 09:00:00,0.0,10.0,2.0,9.0,15724800.0,0.0,2
55548,maligniteit cervix,TC101,M13,SC7,other,39.0,473_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,39312000.0,0.0,2
55628,Metastasen corpus maligniteit uteri (nno),TC603,M14,SC7,DTC339513,47.0,474_2,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,70761600.0,0.0,2
55629,Metastasen corpus maligniteit uteri (nno),TC603,M14,SC7,DTC339513,47.0,474_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,70761600.0,0.0,2
55660,maligniteit ovarium | tuba,TC103,M16,SC7,DTC339319,55.0,475_2,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,777600.0,0.0,2
55661,maligniteit ovarium | tuba,TC103,M16,SC7,DTC339319,55.0,475_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,777600.0,0.0,2
28457,maligniteit cervix,TC101,M13,SC7,DTC229555,33.0,216_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-29 09:00:00,246240.0,10.0,5.0,9.0,67478400.0,14774400.0,2
56264,maligniteit cervix,TC803,M13,SC7,DTC343853,60.0,481_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-03 09:00:00,0.0,11.0,3.0,9.0,19958400.0,0.0,2
56265,maligniteit cervix,TC803,M13,SC7,DTC343853,60.0,481_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-03 09:00:00,0.0,11.0,3.0,9.0,19958400.0,0.0,2
56339,maligniteit cervix,TC3301,DC822,SC13,DTC345666,61.0,483_2,370403S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-07 09:00:00,0.0,11.0,0.0,9.0,1987200.0,0.0,2
56340,maligniteit cervix,TC3301,DC822,SC13,DTC345666,61.0,483_2,370443S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-07 09:00:00,0.0,11.0,0.0,9.0,1987200.0,0.0,2
56368,maligniteit vulva,TC101,M11,SC7,other,81.0,485_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,64108800.0,0.0,2
56369,maligniteit vulva,TC101,M11,SC7,other,81.0,485_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,64108800.0,0.0,2
56408,maligniteit cervix,TC101,M13,SC7,other,44.0,488_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,70761600.0,0.0,2
56409,maligniteit cervix,TC101,M13,SC7,other,44.0,488_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,70761600.0,0.0,2
56790,maligniteit ovarium | tuba,TC101,M16,SC7,other,83.0,491_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,38707200.0,0.0,2
56791,maligniteit ovarium | tuba,TC101,M16,SC7,other,83.0,491_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,38707200.0,0.0,2
56952,maligniteit cervix,TC101,M13,SC7,other,53.0,493_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-10 09:00:00,0.0,11.0,3.0,9.0,32054400.0,0.0,2
56953,maligniteit cervix,TC101,M13,SC7,other,53.0,493_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-10 09:00:00,0.0,11.0,3.0,9.0,32054400.0,0.0,2
40296,maligniteit ovarium | tuba,TC101,M16,SC7,DTC274937,64.0,335_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-14 09:00:00,168480.0,11.0,0.0,9.0,70934400.0,10108800.0,2
57868,maligniteit vulva,TC803,M11,SC7,DTC351086,82.0,496_2,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-14 09:00:00,0.0,11.0,0.0,9.0,3283200.0,0.0,2
57869,maligniteit vulva,TC803,M11,SC7,DTC351086,82.0,496_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-14 09:00:00,0.0,11.0,0.0,9.0,3283200.0,0.0,2
57926,Gynaecologische tumoren,TC61,DC106,SC7,DTC352851,44.0,498_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-16 09:00:00,0.0,11.0,2.0,9.0,66355200.0,0.0,2
57927,Gynaecologische tumoren,TC61,DC106,SC7,DTC352851,44.0,498_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-16 09:00:00,0.0,11.0,2.0,9.0,66355200.0,0.0,2
58173,maligniteit cervix,TC103,M13,SC7,DTC355699,70.0,501_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-21 09:00:00,0.0,11.0,0.0,9.0,6652800.0,0.0,2
58174,maligniteit cervix,TC103,M13,SC7,DTC355699,70.0,501_2,370504A,LBAC,Section 4,SC87,Medical Microbiology,1.0,2005-11-21 09:00:00,0.0,11.0,0.0,9.0,6652800.0,0.0,2
58241,maligniteit ovarium | tuba,TC803,M16,SC7,DTC355558,50.0,502_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-21 09:00:00,0.0,11.0,0.0,9.0,9936000.0,0.0,2
58242,maligniteit ovarium | tuba,TC803,M16,SC7,DTC355558,50.0,502_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-21 09:00:00,0.0,11.0,0.0,9.0,9936000.0,0.0,2
58340,maligniteit vulva,TC503,M11,SC7,DTC359445,70.0,504_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-24 09:00:00,0.0,11.0,3.0,9.0,48124800.0,0.0,2
58341,maligniteit vulva,TC503,M11,SC7,DTC359445,70.0,504_2,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2005-11-24 09:00:00,0.0,11.0,3.0,9.0,48124800.0,0.0,2
58367,Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC359799,35.0,505_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-24 09:00:00,0.0,11.0,3.0,9.0,68342400.0,0.0,2
58368,Maligne nieuwvormingen ovarium (nno),TC101,M16,SC7,DTC359799,35.0,505_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-24 09:00:00,0.0,11.0,3.0,9.0,68342400.0,0.0,2
58662,maligniteit cervix,TC101,M13,SC7,DTC373622,35.0,508_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-29 09:00:00,0.0,11.0,1.0,9.0,18835200.0,0.0,2
27097,maligniteit cervix,TC101,M13,SC7,DTC221377,42.0,202_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,32227200.0,18748800.0,2
30044,maligniteit endometrium,TC101,M14,SC7,DTC246740,55.0,232_2,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,64627200.0,16502400.0,2
43754,maligniteit cervix,TC101,M13,SC7,other,48.0,362_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,64627200.0,9417600.0,2
49134,Gynaecologische tumoren,TC61,DC106,SC7,DTC363167,89.0,391_2,other,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,72576000.0,7257600.0,2
54461,maligniteit cervix,TC101,M13,SC7,other,80.0,465_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,32054400.0,3196800.0,2
58764,maligniteit cervix,TC103,M13,SC7,DTC363510,88.0,509_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,10886400.0,0.0,2
58765,maligniteit cervix,TC103,M13,SC7,DTC363510,88.0,509_2,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,10886400.0,0.0,2
58867,Ongediff. adenoca. ovarium st IIIc,TC803,M16,SC7,DTC363618,69.0,511_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,1296000.0,0.0,2
58868,Ongediff. adenoca. ovarium st IIIc,TC803,M16,SC7,DTC363618,69.0,511_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,1296000.0,0.0,2
29064,maligniteit cervix,TC61,DC106,SC61,other,53.0,221_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-07 09:00:00,0.0,12.0,2.0,9.0,40608000.0,17884800.0,2
52023,maligniteit vulva,TC101,M11,SC7,DTC368248,52.0,434_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-07 09:00:00,0.0,12.0,2.0,9.0,69465600.0,5961600.0,2
43747,maligniteit cervix,TC101,M13,SC7,other,67.0,361_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,0.0,10800000.0,2
58660,maligniteit cervix,TC101,M13,SC7,DTC373622,35.0,508_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,17539200.0,1296000.0,2
63028,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC383467,48.0,525_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,63504000.0,0.0,2
63029,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC383467,48.0,525_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,63504000.0,0.0,2
63625,Maligne neoplasma cervix uteri,TC61,DC106,SC61,DTC392802,38.0,526_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,56332800.0,0.0,2
63626,Maligne neoplasma cervix uteri,TC61,DC106,SC61,DTC392802,38.0,526_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,56332800.0,0.0,2
63664,maligniteit endometrium,TC101,M14,SC7,other,79.0,528_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-19 09:00:00,0.0,12.0,0.0,9.0,65577600.0,0.0,2
64138,maligniteit cervix,TC803,M13,SC7,DTC379572,55.0,531_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-21 09:00:00,0.0,12.0,2.0,9.0,69552000.0,0.0,2
64139,maligniteit cervix,TC803,M13,SC7,DTC379572,55.0,531_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-21 09:00:00,0.0,12.0,2.0,9.0,69552000.0,0.0,2
65031,maligniteit cervix,TC113,M13,SC61,DTC393928,62.0,533_2,370401S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-23 09:00:00,0.0,12.0,4.0,9.0,8726400.0,0.0,2
65032,maligniteit cervix,TC113,M13,SC61,DTC393928,62.0,533_2,370488T,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-23 09:00:00,0.0,12.0,4.0,9.0,8726400.0,0.0,2
67483,maligniteit vagina,TC113,M12,SC7,DTC385086,63.0,538_2,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2005-12-30 09:00:00,0.0,12.0,4.0,9.0,59097600.0,0.0,2
67484,maligniteit vagina,TC113,M12,SC7,DTC385086,63.0,538_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-30 09:00:00,0.0,12.0,4.0,9.0,59097600.0,0.0,2
67828,maligniteit cervix,TC103,M13,SC61,DTC386013,36.0,539_2,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-01-02 09:00:00,0.0,1.0,0.0,9.0,31104000.0,0.0,2
67829,maligniteit cervix,TC103,M13,SC61,DTC386013,36.0,539_2,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2006-01-02 09:00:00,0.0,1.0,0.0,9.0,31104000.0,0.0,2
69447,Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC392898,41.0,543_2,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-04 09:00:00,0.0,1.0,2.0,9.0,55728000.0,0.0,2
69448,Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC392898,41.0,543_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-04 09:00:00,0.0,1.0,2.0,9.0,55728000.0,0.0,2
69479,maligniteit cervix,TC61,DC106,SC61,other,68.0,545_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-01-05 09:00:00,0.0,1.0,3.0,9.0,25920000.0,0.0,2
69698,Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC394833,74.0,548_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,65836800.0,0.0,2
69699,Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC394833,74.0,548_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,65836800.0,0.0,2
70250,Gynaecologische tumoren,TC13,DC106,SC7,DTC394447,68.0,549_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,68256000.0,0.0,2
70251,Gynaecologische tumoren,TC13,DC106,SC7,DTC394447,68.0,549_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,68256000.0,0.0,2
70472,maligniteit endometrium,TC101,M14,SC7,other,74.0,552_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,25401600.0,0.0,2
70473,maligniteit endometrium,TC101,M14,SC7,other,74.0,552_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,25401600.0,0.0,2
70641,maligniteit ovarium | tuba,TC101,M16,SC7,DTC395261,81.0,555_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,0.0,0.0,2
70642,maligniteit ovarium | tuba,TC101,M16,SC7,DTC395261,81.0,555_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,0.0,0.0,2
70862,maligniteit cervix,TC101,M13,SC61,DTC575145,91.0,558_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-01-16 09:00:00,0.0,1.0,0.0,9.0,21168000.0,0.0,2
70863,maligniteit cervix,TC101,M13,SC61,DTC575145,91.0,558_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-01-16 09:00:00,0.0,1.0,0.0,9.0,21168000.0,0.0,2
71139,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC438856,46.0,559_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-16 09:00:00,0.0,1.0,0.0,9.0,35251200.0,0.0,2
71140,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC438856,46.0,559_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-16 09:00:00,0.0,1.0,0.0,9.0,35251200.0,0.0,2
71346,maligniteit cervix,TC803,M13,SC7,DTC399410,41.0,560_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,19180800.0,0.0,2
71347,maligniteit cervix,TC803,M13,SC7,DTC399410,41.0,560_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,19180800.0,0.0,2
71385,maligniteit cervix,TC101,M13,SC7,DTC398986,38.0,561_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,33868800.0,0.0,2
72159,maligniteit myometrium,TC803,M15,SC61,DTC574624,63.0,565_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,23587200.0,0.0,2
72160,maligniteit myometrium,TC803,M15,SC61,DTC574624,63.0,565_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,23587200.0,0.0,2
72198,maligniteit cervix,TC101,M13,SC7,other,40.0,567_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,65923200.0,0.0,2
72199,maligniteit cervix,TC101,M13,SC7,other,40.0,567_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,65923200.0,0.0,2
72206,Gynaecologische tumoren,TC61,DC106,SC7,other,59.0,568_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,56332800.0,0.0,2
72249,maligniteit ovarium | tuba,TC101,M16,SC7,DTC400130,46.0,570_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,60480000.0,0.0,2
72250,maligniteit ovarium | tuba,TC101,M16,SC7,DTC400130,46.0,570_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,60480000.0,0.0,2
72886,maligniteit cervix,TC101,M13,SC7,other,38.0,573_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-25 09:00:00,0.0,1.0,2.0,9.0,64627200.0,0.0,2
72887,maligniteit cervix,TC101,M13,SC7,other,38.0,573_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-25 09:00:00,0.0,1.0,2.0,9.0,64627200.0,0.0,2
39107,maligniteit vulva,TC101,M11,SC7,other,73.0,331_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,54432000.0,16934400.0,2
73894,maligniteit vulva,TC101,M11,SC7,other,81.0,583_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,37497600.0,0.0,2
73895,maligniteit vulva,TC101,M11,SC7,other,81.0,583_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,37497600.0,0.0,2
74412,maligniteit ovarium | tuba,TC101,M16,SC7,DTC406503,34.0,587_2,372440A,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,54432000.0,0.0,2
74413,maligniteit ovarium | tuba,TC101,M16,SC7,DTC406503,34.0,587_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,54432000.0,0.0,2
75119,Maligne nieuwvormingen corpus uteri (ov),TC13,DC106,SC61,DTC574868,83.0,592_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,4406400.0,0.0,2
75120,Maligne nieuwvormingen corpus uteri (ov),TC13,DC106,SC61,DTC574868,83.0,592_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,4406400.0,0.0,2
75855,Plav.celcarc. vulva: st IVa,TC113,M11,SC61,DTC434512,82.0,596_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-13 09:00:00,0.0,2.0,0.0,9.0,8726400.0,0.0,2
75856,Plav.celcarc. vulva: st IVa,TC113,M11,SC61,DTC434512,82.0,596_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-13 09:00:00,0.0,2.0,0.0,9.0,8726400.0,0.0,2
76148,maligniteit ovarium | tuba,TC803,M16,SC7,DTC416155,76.0,597_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-13 09:00:00,0.0,2.0,0.0,9.0,24537600.0,0.0,2
76149,maligniteit ovarium | tuba,TC803,M16,SC7,DTC416155,76.0,597_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-13 09:00:00,0.0,2.0,0.0,9.0,24537600.0,0.0,2
76285,Plaveiselcelcarinoom vulva (nno),TC103,M11,SC7,DTC405039,74.0,600_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-15 09:00:00,0.0,2.0,2.0,9.0,58060800.0,0.0,2
76286,Plaveiselcelcarinoom vulva (nno),TC103,M11,SC7,DTC405039,74.0,600_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-15 09:00:00,0.0,2.0,2.0,9.0,58060800.0,0.0,2
76318,maligniteit cervix,TC101,M13,SC7,other,51.0,605_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,7257600.0,0.0,2
76319,maligniteit cervix,TC101,M13,SC7,other,51.0,605_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,7257600.0,0.0,2
76604,Gynaecologische tumoren,TC61,DC106,SC7,DTC418694,62.0,607_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,61084800.0,0.0,2
76605,Gynaecologische tumoren,TC61,DC106,SC7,DTC418694,62.0,607_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,61084800.0,0.0,2
76618,maligniteit vulva,TC101,M11,SC7,other,68.0,609_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,53568000.0,0.0,2
76619,maligniteit vulva,TC101,M11,SC7,other,68.0,609_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,53568000.0,0.0,2
76719,maligniteit vulva,TC803,M11,SC7,DTC423382,84.0,610_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,29548800.0,0.0,2
76720,maligniteit vulva,TC803,M11,SC7,DTC423382,84.0,610_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,29548800.0,0.0,2
76749,maligniteit cervix,TC101,M13,SC7,other,38.0,611_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,33264000.0,0.0,2
76750,maligniteit cervix,TC101,M13,SC7,other,38.0,611_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,33264000.0,0.0,2
76753,maligniteit cervix,TC101,M13,SC7,other,42.0,612_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,34473600.0,0.0,2
76754,maligniteit cervix,TC101,M13,SC7,other,42.0,612_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,34473600.0,0.0,2
76761,maligniteit endometrium,TC101,M14,SC7,DTC423064,59.0,613_2,378619A,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,54345600.0,0.0,2
76762,maligniteit endometrium,TC101,M14,SC7,DTC423064,59.0,613_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-23 09:00:00,0.0,2.0,3.0,9.0,54345600.0,0.0,2
77077,maligniteit cervix,TC113,M13,SC7,DTC427950,52.0,618_2,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-02 09:00:00,0.0,3.0,3.0,9.0,604800.0,0.0,2
77078,maligniteit cervix,TC113,M13,SC7,DTC427950,52.0,618_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-02 09:00:00,0.0,3.0,3.0,9.0,604800.0,0.0,2
78025,Maligne neoplasma cervix uteri,TC61,DC822,SC61,DTC443333,41.0,622_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-07 09:00:00,0.0,3.0,1.0,9.0,63763200.0,0.0,2
78026,Maligne neoplasma cervix uteri,TC61,DC822,SC61,DTC443333,41.0,622_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-07 09:00:00,0.0,3.0,1.0,9.0,63763200.0,0.0,2
79514,maligniteit endometrium,TC703,M14,SC7,DTC431739,65.0,626_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-08 09:00:00,0.0,3.0,2.0,9.0,3542400.0,0.0,2
79515,maligniteit endometrium,TC703,M14,SC7,DTC431739,65.0,626_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-08 09:00:00,0.0,3.0,2.0,9.0,3542400.0,0.0,2
80348,maligniteit vagina,TC103,M12,SC7,DTC475355,85.0,631_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,7344000.0,0.0,2
80833,Gynaecologische tumoren,TC23,DC106,SC61,DTC785440,78.0,636_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-14 09:00:00,0.0,3.0,1.0,9.0,53395200.0,0.0,2
80834,Gynaecologische tumoren,TC23,DC106,SC61,DTC785440,78.0,636_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-03-14 09:00:00,0.0,3.0,1.0,9.0,53395200.0,0.0,2
80915,maligniteit vulva,TC603,M11,SC61,DTC575456,79.0,637_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,17712000.0,0.0,2
80916,maligniteit vulva,TC603,M11,SC61,DTC575456,79.0,637_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,17712000.0,0.0,2
80978,maligniteit cervix,TC101,DC106,SC7,other,74.0,641_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,63417600.0,0.0,2
80321,maligniteit vagina,TC103,M12,SC7,DTC475355,85.0,631_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-16 09:00:00,0.0,3.0,3.0,9.0,7084800.0,259200.0,2
82039,maligniteit vagina,TC101,M12,SC7,DTC440812,82.0,648_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,2
82040,maligniteit vagina,TC101,M12,SC7,DTC440812,82.0,648_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,2
82070,maligniteit cervix,TC101,M13,SC7,other,40.0,649_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,2419200.0,0.0,2
82075,maligniteit cervix,TC61,DC106,SC61,other,42.0,650_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,23673600.0,0.0,2
82202,maligniteit myometrium,TC101,M15,SC7,other,63.0,652_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,32054400.0,0.0,2
82643,maligniteit ovarium | tuba,TC101,M16,SC7,other,40.0,654_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,2
82644,maligniteit ovarium | tuba,TC101,M16,SC7,other,40.0,654_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,2
83671,"Plaveiselcelca, cervix st Ia2",TC803,M13,SC7,DTC549744,40.0,668_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-05 09:00:00,0.0,4.0,2.0,9.0,47174400.0,0.0,2
83672,"Plaveiselcelca, cervix st Ia2",TC803,M13,SC7,DTC549744,40.0,668_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-05 09:00:00,0.0,4.0,2.0,9.0,47174400.0,0.0,2
84132,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC450231,75.0,670_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-05 09:00:00,0.0,4.0,2.0,9.0,3283200.0,0.0,2
84133,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC450231,75.0,670_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-05 09:00:00,0.0,4.0,2.0,9.0,3283200.0,0.0,2
84221,Recidieven corpus maligniteit uteri (nno),TC803,M14,SC7,DTC451132,63.0,671_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-06 09:00:00,0.0,4.0,3.0,9.0,58060800.0,0.0,2
84222,Recidieven corpus maligniteit uteri (nno),TC803,M14,SC7,DTC451132,63.0,671_2,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-06 09:00:00,0.0,4.0,3.0,9.0,58060800.0,0.0,2
37221,maligniteit vulva,TC101,M11,SC7,other,84.0,305_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,0.0,24192000.0,2
69477,maligniteit cervix,TC61,DC106,SC61,other,68.0,545_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,17539200.0,8380800.0,2
85007,Gynaecologische tumoren,TC61,DC106,SC7,other,72.0,677_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,43545600.0,0.0,2
85008,Gynaecologische tumoren,TC61,DC106,SC7,other,72.0,677_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,43545600.0,0.0,2
85515,Maligne neoplasma ovarium,TC3101,DC821,SC13,DTC464275,61.0,678_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,60307200.0,0.0,2
85516,Maligne neoplasma ovarium,TC3101,DC821,SC13,DTC464275,61.0,678_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,60307200.0,0.0,2
85658,maligniteit ovarium | tuba,TC803,M16,SC7,DTC456784,68.0,680_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-13 09:00:00,0.0,4.0,3.0,9.0,2419200.0,0.0,2
85659,maligniteit ovarium | tuba,TC803,M16,SC7,DTC456784,68.0,680_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-13 09:00:00,0.0,4.0,3.0,9.0,2419200.0,0.0,2
82069,maligniteit cervix,TC101,M13,SC7,other,40.0,649_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-19 09:00:00,40320.0,4.0,2.0,9.0,0.0,2419200.0,2
85842,maligniteit vulva,TC101,M11,SC7,other,62.0,682_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,50198400.0,0.0,2
86257,maligniteit ovarium | tuba,TC102,M16,SC7,DTC458989,27.0,687_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,49593600.0,0.0,2
86258,maligniteit ovarium | tuba,TC102,M16,SC7,DTC458989,27.0,687_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,49593600.0,0.0,2
86307,maligniteit myometrium,TC101,M15,SC7,other,58.0,690_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-27 09:00:00,0.0,4.0,3.0,9.0,49507200.0,0.0,2
86308,maligniteit myometrium,TC101,M15,SC7,other,58.0,690_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-27 09:00:00,0.0,4.0,3.0,9.0,49507200.0,0.0,2
86893,maligniteit ovarium | tuba,TC101,M16,SC7,DTC470100,65.0,695_2,378453A,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-04 09:00:00,0.0,5.0,3.0,9.0,6739200.0,0.0,2
86894,maligniteit ovarium | tuba,TC101,M16,SC7,DTC470100,65.0,695_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-04 09:00:00,0.0,5.0,3.0,9.0,6739200.0,0.0,2
87243,maligniteit vulva,TC101,M11,SC7,DTC473750,86.0,700_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,48988800.0,0.0,2
87244,maligniteit vulva,TC101,M11,SC7,DTC473750,86.0,700_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,48988800.0,0.0,2
87245,"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,other,71.0,701_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,2
87246,"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,other,71.0,701_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,2
88133,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC491400,59.0,711_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-17 09:00:00,0.0,5.0,2.0,9.0,39744000.0,0.0,2
88134,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC491400,59.0,711_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-17 09:00:00,0.0,5.0,2.0,9.0,39744000.0,0.0,2
88161,maligne nieuwvormingen vulva (nno),TC101,M11,SC7,other,84.0,712_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-18 09:00:00,0.0,5.0,3.0,9.0,0.0,0.0,2
88162,maligne nieuwvormingen vulva (nno),TC101,M11,SC7,other,84.0,712_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-18 09:00:00,0.0,5.0,3.0,9.0,0.0,0.0,2
88349,"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC481124,41.0,716_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-19 09:00:00,0.0,5.0,4.0,9.0,28166400.0,0.0,2
88350,"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC481124,41.0,716_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-19 09:00:00,0.0,5.0,4.0,9.0,28166400.0,0.0,2
88734,Gynaecologische tumoren,TC603,DC106,SC61,DTC785367,68.0,720_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-24 09:00:00,0.0,5.0,2.0,9.0,53913600.0,0.0,2
88735,Gynaecologische tumoren,TC603,DC106,SC61,DTC785367,68.0,720_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-24 09:00:00,0.0,5.0,2.0,9.0,53913600.0,0.0,2
89282,Maligne neoplasma cervix uteri,TC3201,M13,SC61,DTC500735,80.0,723_2,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2006-05-29 09:00:00,0.0,5.0,0.0,9.0,19612800.0,0.0,2
89283,Maligne neoplasma cervix uteri,TC3201,M13,SC61,DTC500735,80.0,723_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-29 09:00:00,0.0,5.0,0.0,9.0,19612800.0,0.0,2
89993,"Plaveiselcelca, cervix st Ib",TC503,M13,SC7,DTC543244,35.0,726_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-06-02 09:00:00,0.0,6.0,4.0,9.0,5356800.0,0.0,2
89994,"Plaveiselcelca, cervix st Ib",TC503,M13,SC7,DTC543244,35.0,726_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-02 09:00:00,0.0,6.0,4.0,9.0,5356800.0,0.0,2
90009,Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC575385,68.0,727_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-02 09:00:00,0.0,6.0,4.0,9.0,3542400.0,0.0,2
90010,Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC575385,68.0,727_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-02 09:00:00,0.0,6.0,4.0,9.0,3542400.0,0.0,2
90220,Plav.celcarc. vulva: (st onbekend),TC101,M11,SC7,other,64.0,729_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-06-07 09:00:00,0.0,6.0,2.0,9.0,0.0,0.0,2
90221,Plav.celcarc. vulva: (st onbekend),TC101,M11,SC7,other,64.0,729_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-07 09:00:00,0.0,6.0,2.0,9.0,0.0,0.0,2
91025,Gynaecologische tumoren,TC61,DC106,SC7,DTC495023,53.0,736_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-12 09:00:00,0.0,6.0,0.0,9.0,31708800.0,0.0,2
91026,Gynaecologische tumoren,TC61,DC106,SC7,DTC495023,53.0,736_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-12 09:00:00,0.0,6.0,0.0,9.0,31708800.0,0.0,2
91640,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-14 09:00:00,0.0,6.0,2.0,9.0,36288000.0,0.0,2
91641,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC521172,44.0,740_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-14 09:00:00,0.0,6.0,2.0,9.0,36288000.0,0.0,2
92993,Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,14688000.0,0.0,2
92994,Plav.celcarc. vulva: st IVa,TC13,DC106,SC61,DTC785602,84.0,743_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,14688000.0,0.0,2
93074,Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,34646400.0,0.0,2
93075,Adenoca: corpus uteri st Ib,TC101,M14,SC61,DTC561769,67.0,744_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,34646400.0,0.0,2
29178,Gynaecologische tumoren,TC61,DC106,SC7,other,72.0,226_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-21 09:00:00,0.0,6.0,2.0,9.0,28425600.0,34473600.0,2
82073,maligniteit cervix,TC61,DC106,SC61,other,42.0,650_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-21 09:00:00,0.0,6.0,2.0,9.0,15811200.0,7862400.0,2
94377,maligniteit vulva,TC101,M11,SC7,other,67.0,751_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-28 09:00:00,0.0,6.0,2.0,9.0,35251200.0,0.0,2
94378,maligniteit vulva,TC101,M11,SC7,other,67.0,751_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-28 09:00:00,0.0,6.0,2.0,9.0,35251200.0,0.0,2
94582,"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-30 09:00:00,0.0,6.0,4.0,9.0,16848000.0,0.0,2
94583,"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC510554,50.0,758_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-06-30 09:00:00,0.0,6.0,4.0,9.0,16848000.0,0.0,2
94636,maligniteit endometrium,TC61,DC106,SC61,other,49.0,762_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-05 09:00:00,0.0,7.0,2.0,9.0,21859200.0,0.0,2
94637,maligniteit endometrium,TC61,DC106,SC61,other,49.0,762_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-05 09:00:00,0.0,7.0,2.0,9.0,21859200.0,0.0,2
95224,maligniteit cervix,TC101,M13,SC7,other,49.0,765_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-06 09:00:00,0.0,7.0,3.0,9.0,0.0,0.0,2
95225,maligniteit cervix,TC101,M13,SC7,other,49.0,765_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-06 09:00:00,0.0,7.0,3.0,9.0,0.0,0.0,2
95450,"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,other,47.0,768_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-12 09:00:00,0.0,7.0,2.0,9.0,0.0,0.0,2
95451,"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,other,47.0,768_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-12 09:00:00,0.0,7.0,2.0,9.0,0.0,0.0,2
95458,Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770_2,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-12 09:00:00,0.0,7.0,2.0,9.0,518400.0,0.0,2
95459,Niet epitheliale mal. nieuwv. ovarium st IIIa,TC101,M16,SC7,DTC518436,69.0,770_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-12 09:00:00,0.0,7.0,2.0,9.0,518400.0,0.0,2
95575,maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 09:00:00,0.0,7.0,3.0,9.0,13219200.0,0.0,2
95576,maligniteit ovarium | tuba,TC803,M16,SC7,DTC519205,66.0,771_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-13 09:00:00,0.0,7.0,3.0,9.0,13219200.0,0.0,2
95821,maligniteit vulva,TC101,M11,SC7,other,74.0,775_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,0.0,0.0,2
95822,maligniteit vulva,TC101,M11,SC7,other,74.0,775_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,0.0,0.0,2
95898,Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776_2,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,52617600.0,0.0,2
95899,Adenoca: corpus uteri st IIIa,TC603,M14,SC7,DTC523258,66.0,776_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,52617600.0,0.0,2
95905,Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777_2,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,604800.0,0.0,2
95906,Adenoca: corpus uteri st IIa,TC101,M14,SC7,DTC523199,71.0,777_2,AC375004,BLOB,Section 4,SC86,General Lab Clinical Chemistry,2.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,604800.0,0.0,2
95944,"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778_2,AC355409,LVPT,Section 4,SC88,Pathology,1.0,2006-07-20 09:00:00,0.0,7.0,3.0,9.0,518400.0,0.0,2
95945,"Plaveiselcelca, cervix st IIIb",TC101,M13,SC7,DTC524974,66.0,778_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-20 09:00:00,0.0,7.0,3.0,9.0,518400.0,0.0,2
95971,Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-21 09:00:00,0.0,7.0,4.0,9.0,604800.0,0.0,2
95972,Adenoca: corpus uteri st Ic,TC101,M14,SC7,DTC525166,59.0,780_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-21 09:00:00,0.0,7.0,4.0,9.0,604800.0,0.0,2
96014,Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-24 09:00:00,0.0,7.0,0.0,9.0,36288000.0,0.0,2
96015,Gynaecologische tumoren,TC61,DC106,SC7,DTC525955,40.0,781_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-24 09:00:00,0.0,7.0,0.0,9.0,36288000.0,0.0,2
96860,maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 09:00:00,0.0,7.0,0.0,9.0,0.0,0.0,2
96861,maligniteit endometrium,TC101,M14,SC7,DTC530455,55.0,789_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-31 09:00:00,0.0,7.0,0.0,9.0,0.0,0.0,2
98392,maligniteit endometrium,TC101,M14,SC7,other,74.0,799_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-21 09:00:00,0.0,8.0,0.0,9.0,0.0,0.0,2
98393,maligniteit endometrium,TC101,M14,SC7,other,74.0,799_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-21 09:00:00,0.0,8.0,0.0,9.0,0.0,0.0,2
99733,maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-21 09:00:00,0.0,8.0,0.0,9.0,6393600.0,0.0,2
99734,maligniteit ovarium | tuba,TC3103,DC821,SC13,DTC592071,60.0,800_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-21 09:00:00,0.0,8.0,0.0,9.0,6393600.0,0.0,2
100067,Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-23 09:00:00,0.0,8.0,2.0,9.0,46569600.0,0.0,2
100068,Maligne neoplasma cervix uteri,TC81,DC822,SC61,DTC567064,29.0,801_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-23 09:00:00,0.0,8.0,2.0,9.0,46569600.0,0.0,2
100095,maligniteit ovarium | tuba,TC101,M16,SC7,other,67.0,802_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-23 09:00:00,0.0,8.0,2.0,9.0,0.0,0.0,2
100096,maligniteit ovarium | tuba,TC101,M16,SC7,other,67.0,802_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-23 09:00:00,0.0,8.0,2.0,9.0,0.0,0.0,2
100105,maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-08-24 09:00:00,0.0,8.0,3.0,9.0,44150400.0,0.0,2
100106,maligniteit ovarium | tuba,TC101,M16,SC7,DTC545423,39.0,803_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-24 09:00:00,0.0,8.0,3.0,9.0,44150400.0,0.0,2
100455,maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-25 09:00:00,0.0,8.0,4.0,9.0,432000.0,0.0,2
100456,maligniteit vulva,TC101,M11,SC7,DTC546701,82.0,805_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-25 09:00:00,0.0,8.0,4.0,9.0,432000.0,0.0,2
100776,maligniteit endometrium,TC61,DC106,SC61,other,45.0,808_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-30 09:00:00,0.0,8.0,2.0,9.0,16416000.0,0.0,2
100777,maligniteit endometrium,TC61,DC106,SC61,other,45.0,808_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-30 09:00:00,0.0,8.0,2.0,9.0,16416000.0,0.0,2
52028,maligniteit cervix,TC101,M13,SC7,other,36.0,435_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-31 09:00:00,483840.0,8.0,3.0,9.0,5443200.0,29030400.0,2
101759,Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-01 09:00:00,0.0,9.0,4.0,9.0,20563200.0,0.0,2
101760,Adenoca: corpus uteri st Ib,TC613,M14,SC7,DTC550984,60.0,811_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-01 09:00:00,0.0,9.0,4.0,9.0,20563200.0,0.0,2
101798,"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-04 09:00:00,0.0,9.0,0.0,9.0,16934400.0,0.0,2
101799,"Plaveiselcelca, cervix st IIb",TC61,DC106,SC61,DTC795001,57.0,812_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-04 09:00:00,0.0,9.0,0.0,9.0,16934400.0,0.0,2
101861,Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 09:00:00,0.0,9.0,0.0,9.0,47952000.0,0.0,2
101862,Gynaecologische tumoren,TC23,DC106,SC7,DTC551864,68.0,813_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-04 09:00:00,0.0,9.0,0.0,9.0,47952000.0,0.0,2
103187,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-08 09:00:00,0.0,9.0,4.0,9.0,33177600.0,0.0,2
103188,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC555229,40.0,816_2,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-09-08 09:00:00,0.0,9.0,4.0,9.0,33177600.0,0.0,2
103246,maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-11 09:00:00,0.0,9.0,0.0,9.0,6912000.0,0.0,2
103247,maligniteit endometrium,TC13,DC106,SC61,DTC785637,85.0,818_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-11 09:00:00,0.0,9.0,0.0,9.0,6912000.0,0.0,2
80976,maligniteit cervix,TC101,DC106,SC7,other,74.0,641_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-14 09:00:00,0.0,9.0,3.0,9.0,47606400.0,15811200.0,2
105427,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 09:00:00,0.0,9.0,1.0,9.0,44236800.0,0.0,2
105428,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC593140,38.0,824_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-19 09:00:00,0.0,9.0,1.0,9.0,44236800.0,0.0,2
106331,"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-26 09:00:00,0.0,9.0,1.0,9.0,17625600.0,0.0,2
106332,"Plaveiselcelca, cervix st IIb",TC113,M13,SC61,DTC582622,37.0,828_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-09-26 09:00:00,0.0,9.0,1.0,9.0,17625600.0,0.0,2
106824,maligniteit cervix,TC101,M13,SC7,other,38.0,831_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-04 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
106825,maligniteit cervix,TC101,M13,SC7,other,38.0,831_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-04 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
107388,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-13 09:00:00,0.0,10.0,4.0,9.0,32486400.0,0.0,2
107389,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC785616,58.0,834_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-13 09:00:00,0.0,10.0,4.0,9.0,32486400.0,0.0,2
107417,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,50.0,835_2,other,LVPT,Section 4,SC88,Pathology,1.0,2006-10-18 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
107418,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,50.0,835_2,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-10-18 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
107637,Adenoca: corpus uteri st IIIb,TC703,M14,SC7,DTC584816,71.0,836_2,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-18 09:00:00,0.0,10.0,2.0,9.0,30067200.0,0.0,2
107638,Adenoca: corpus uteri st IIIb,TC703,M14,SC7,DTC584816,71.0,836_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-10-18 09:00:00,0.0,10.0,2.0,9.0,30067200.0,0.0,2
72204,Gynaecologische tumoren,TC61,DC106,SC7,other,59.0,568_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-26 09:00:00,0.0,10.0,3.0,9.0,32140800.0,24192000.0,2
107860,maligne nieuwvormingen vulva (nno),TC101,M11,SC7,other,80.0,839_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-26 09:00:00,0.0,10.0,3.0,9.0,0.0,0.0,2
107861,maligne nieuwvormingen vulva (nno),TC101,M11,SC7,other,80.0,839_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-26 09:00:00,0.0,10.0,3.0,9.0,0.0,0.0,2
108066,Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-10-30 09:00:00,0.0,10.0,0.0,9.0,39484800.0,0.0,2
108067,Maligne nieuwvormingen ovarium (nno),TC803,M16,SC7,DTC591784,33.0,841_2,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-10-30 09:00:00,0.0,10.0,0.0,9.0,39484800.0,0.0,2
85840,maligniteit vulva,TC101,M11,SC7,other,62.0,682_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-01 09:00:00,0.0,11.0,2.0,9.0,33264000.0,16934400.0,2
108528,Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845_2,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-06 09:00:00,0.0,11.0,0.0,9.0,16934400.0,0.0,2
108529,Plav.celcarc. vulva: (st onbekend),TC803,M11,SC61,DTC786416,87.0,845_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 09:00:00,0.0,11.0,0.0,9.0,16934400.0,0.0,2
109932,"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851_2,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2006-11-13 09:00:00,0.0,11.0,0.0,9.0,31017600.0,0.0,2
109933,"Plaveiselcelca, cervix st Ib",TC613,M13,SC61,DTC617130,34.0,851_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 09:00:00,0.0,11.0,0.0,9.0,31017600.0,0.0,2
111290,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-20 09:00:00,0.0,11.0,0.0,9.0,29635200.0,0.0,2
111291,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC606164,30.0,856_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-20 09:00:00,0.0,11.0,0.0,9.0,29635200.0,0.0,2
111365,Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-20 09:00:00,0.0,11.0,0.0,9.0,7257600.0,0.0,2
111366,Sarcoom corpus uteri: FIGO st onbek.,TC603,M15,SC7,DTC606137,47.0,857_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-20 09:00:00,0.0,11.0,0.0,9.0,7257600.0,0.0,2
55546,maligniteit cervix,TC101,M13,SC7,other,39.0,473_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-30 09:00:00,0.0,11.0,3.0,9.0,4838400.0,34473600.0,2
112115,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 09:00:00,0.0,12.0,3.0,9.0,25401600.0,0.0,2
112116,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC61,DTC786376,92.0,868_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-07 09:00:00,0.0,12.0,3.0,9.0,25401600.0,0.0,2
112149,maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,869_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-07 09:00:00,0.0,12.0,3.0,9.0,86400.0,0.0,2
112150,maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,869_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-07 09:00:00,0.0,12.0,3.0,9.0,86400.0,0.0,2
112579,Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 09:00:00,0.0,12.0,0.0,9.0,35078400.0,0.0,2
112580,Maligne nieuwvormingen ovarium (nno),TC803,M16,SC13,DTC620890,68.0,871_2,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-11 09:00:00,0.0,12.0,0.0,9.0,35078400.0,0.0,2
112702,Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 09:00:00,0.0,12.0,2.0,9.0,7689600.0,0.0,2
112703,Clearcel carcinoom corpus uteri (nno),TC803,M14,SC7,DTC623075,67.0,872_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 09:00:00,0.0,12.0,2.0,9.0,7689600.0,0.0,2
112973,Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 09:00:00,0.0,12.0,3.0,9.0,39312000.0,0.0,2
112974,Niet epitheliale mal. nieuwv. ovarium (nno),TC603,M16,SC7,DTC623746,52.0,875_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-14 09:00:00,0.0,12.0,3.0,9.0,39312000.0,0.0,2
71379,maligniteit cervix,TC101,M13,SC7,DTC398986,38.0,561_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-12-15 09:00:00,0.0,12.0,4.0,9.0,5270400.0,28598400.0,2
113156,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-15 09:00:00,0.0,12.0,4.0,9.0,35510400.0,0.0,2
113157,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC624677,42.0,876_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-15 09:00:00,0.0,12.0,4.0,9.0,35510400.0,0.0,2
113226,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 09:00:00,0.0,12.0,2.0,9.0,8553600.0,0.0,2
113227,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC627701,59.0,877_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-20 09:00:00,0.0,12.0,2.0,9.0,8553600.0,0.0,2
63662,maligniteit endometrium,TC101,M14,SC7,other,79.0,528_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-21 09:00:00,0.0,12.0,3.0,9.0,33868800.0,31708800.0,2
113797,Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881_2,other,LVPT,Section 4,SC88,Pathology,1.0,2006-12-27 09:00:00,0.0,12.0,2.0,9.0,35078400.0,0.0,2
113798,Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC632518,74.0,881_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-27 09:00:00,0.0,12.0,2.0,9.0,35078400.0,0.0,2
114074,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 09:00:00,0.0,1.0,2.0,9.0,32745600.0,0.0,2
114075,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC651687,71.0,882_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-10 09:00:00,0.0,1.0,2.0,9.0,32745600.0,0.0,2
114236,Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 09:00:00,0.0,1.0,0.0,9.0,31622400.0,0.0,2
114237,Adenoca:  cervix st Ib,TC803,M13,SC7,DTC644452,42.0,884_2,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-15 09:00:00,0.0,1.0,0.0,9.0,31622400.0,0.0,2
114749,Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-17 09:00:00,0.0,1.0,2.0,9.0,31449600.0,0.0,2
114750,Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC787923,70.0,887_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-17 09:00:00,0.0,1.0,2.0,9.0,31449600.0,0.0,2
114853,Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 09:00:00,0.0,1.0,2.0,9.0,27734400.0,0.0,2
114854,Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC787795,65.0,888_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-17 09:00:00,0.0,1.0,2.0,9.0,27734400.0,0.0,2
116733,Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 09:00:00,0.0,1.0,2.0,9.0,9676800.0,0.0,2
116734,Plav.celcarc. vulva: st III1,TC803,M11,SC7,DTC656176,78.0,895_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-31 09:00:00,0.0,1.0,2.0,9.0,9676800.0,0.0,2
117291,"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 09:00:00,0.0,2.0,0.0,9.0,28598400.0,0.0,2
117292,"Plaveiselcelca, cervix st Ib",TC813,M13,SC7,DTC663222,46.0,899_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-12 09:00:00,0.0,2.0,0.0,9.0,28598400.0,0.0,2
118845,Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 09:00:00,0.0,2.0,0.0,9.0,27302400.0,0.0,2
118846,Clearcel ca: corpus uteri st Ib,TC101,M14,SC61,DTC787818,72.0,909_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-26 09:00:00,0.0,2.0,0.0,9.0,27302400.0,0.0,2
119058,maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 09:00:00,0.0,2.0,1.0,9.0,30931200.0,0.0,2
119059,maligniteit cervix,TC1101,M13,SC61,DTC689148,72.0,910_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-27 09:00:00,0.0,2.0,1.0,9.0,30931200.0,0.0,2
119659,Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-28 09:00:00,0.0,2.0,2.0,9.0,518400.0,0.0,2
119660,Maligne nieuwvormingen ovarium (nno),TC103,M16,SC7,DTC674051,64.0,911_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-28 09:00:00,0.0,2.0,2.0,9.0,518400.0,0.0,2
82200,maligniteit myometrium,TC101,M15,SC7,other,63.0,652_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-03-28 09:00:00,0.0,3.0,2.0,9.0,0.0,32054400.0,2
11966,Recidieven (pre)maligniteit cervix uteri (ov),TC103,M13,SC13,DTC392290,45.0,76_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-12-18 09:00:00,0.0,12.0,1.0,9.0,3974400.0,88992000.0,2
